<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Spectral Ai Inc. — News on 6ix</title>
<link>https://6ix.com/company/spectral-ai-inc</link>
<description>Latest news and press releases for Spectral Ai Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 28 Apr 2026 20:15:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/spectral-ai-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683596d178dffbe2df104b9d.webp</url>
<title>Spectral Ai Inc.</title>
<link>https://6ix.com/company/spectral-ai-inc</link>
</image>
<item>
<title>Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-schedules-2026-first-quarter-financial-results-and-conference-call</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-schedules-2026-first-quarter-financial-results-and-conference-call</guid>
<pubDate>Tue, 28 Apr 2026 20:15:00 GMT</pubDate>
<description>DALLAS, April 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the first quarter ended March 31, 2026 on Tuesday, May 12, 2026 after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the same</description>
</item>
<item>
<title>Spectral AI Announces Annual Meeting of Stockholders</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-announces-annual-meeting-of-stockholders</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-announces-annual-meeting-of-stockholders</guid>
<pubDate>Mon, 20 Apr 2026 20:15:00 GMT</pubDate>
<description>DALLAS, April 20, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that its 2026 Annual Meeting of Stockholders (“Annual Meeting”) will take place at 9:30 a.m. Central Daylight Time on Friday, May 29, 2026. Only stockholders of record at the close of business on April 1, 2026, the record date, will be ent</description>
</item>
<item>
<title>Spectral AI to Feature DeepView® System at 2026 American Burn Association Annual Meeting</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-to-feature-deepviewr-system-at-2026-american-burn-association-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-to-feature-deepviewr-system-at-2026-american-burn-association-annual-meeting</guid>
<pubDate>Thu, 09 Apr 2026 04:00:00 GMT</pubDate>
<description>DeepView System will be on Display at Booth #601 DALLAS, April 09, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”),</description>
</item>
<item>
<title>Spectral AI Names David McGuire, CPA, as Chief Financial Officer</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-names-david-mcguire-cpa-as-chief-financial-officer</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-names-david-mcguire-cpa-as-chief-financial-officer</guid>
<pubDate>Wed, 08 Apr 2026 04:00:00 GMT</pubDate>
<description>DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused</description>
</item>
<item>
<title>Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-announces-2025-fourth-quarter-and-full-year-financial-results-and-introduces-revenue-guidance-for-2026</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-announces-2025-fourth-quarter-and-full-year-financial-results-and-introduces-revenue-guidance-for-2026</guid>
<pubDate>Tue, 24 Mar 2026 04:00:00 GMT</pubDate>
<description>Overview Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 MillionCash Rose to $15.4 Million at December 31, 2025 DALLAS,</description>
</item>
<item>
<title>Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-awarded-dollar317-million-of-barda-funding-to-accelerate-development-of-the-deepviewr-system</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-awarded-dollar317-million-of-barda-funding-to-accelerate-development-of-the-deepviewr-system</guid>
<pubDate>Wed, 18 Mar 2026 04:00:00 GMT</pubDate>
<description>DALLAS, March 18, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused</description>
</item>
<item>
<title>Spectral AI Schedules 2025 Fourth Quarter and Full Year Financial Results and Conference Call</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-schedules-2025-fourth-quarter-and-full-year-financial-results-and-conference-call-3</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-schedules-2025-fourth-quarter-and-full-year-financial-results-and-conference-call-3</guid>
<pubDate>Tue, 10 Mar 2026 12:30:00 GMT</pubDate>
<description>DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2025 on Tuesday, March 24, 2026 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Tim</description>
</item>
<item>
<title>Spectral AI Names Vincent S. Capone as Chief Executive Officer</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-names-vincent-capone-133000578</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-names-vincent-capone-133000578</guid>
<pubDate>Tue, 10 Feb 2026 13:30:00 GMT</pubDate>
<description>DALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the Company’s Board of Directors has appointed Vincent S. Capone as Chief Executive Officer of the Company, effective February 9, 2026. The appointment of Mr. Capone, who currently serves as the Company’s Chief Financial Officer and Ge</description>
</item>
<item>
<title>Spectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-participate-national-burn-133000268</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-participate-national-burn-133000268</guid>
<pubDate>Mon, 02 Feb 2026 13:30:00 GMT</pubDate>
<description>DALLAS, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will join the American Burn Association (ABA) to promote practical, life-saving burn prevention strategies for workplaces of all types during this year’s National Burn Awareness Week. In support of this annual event, Spectral AI wil</description>
</item>
<item>
<title>DeepView™ System Featured at 2025 US Burn Conferences</title>
<link>https://6ix.com/company/spectral-ai-inc/news/deepview-system-featured-2025-us-130000880</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/deepview-system-featured-2025-us-130000880</guid>
<pubDate>Wed, 19 Nov 2025 13:00:00 GMT</pubDate>
<description>DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its prominent role at the Southern Region Burn Conference, held from October 30th – November 2nd in Charleston, South Carolina. The Company was featured in multiple presentations, highlighting its contributions to advancing burn care across</description>
</item>
<item>
<title>Spectral AI Announces 2025 Third Quarter Financial Results</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-announces-2025-third-210000788</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-announces-2025-third-210000788</guid>
<pubDate>Tue, 11 Nov 2025 21:00:00 GMT</pubDate>
<description>Q3 Overview Research & Development Revenue of $3.8 Million; $15.6 Million in YTD Revenue for 2025Strong Cash position of $10.5 Million and progress toward FDA De Novo submission DALLAS, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the third quarter ended September 30, 20</description>
</item>
<item>
<title>Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-schedules-2025-third-200000069</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-schedules-2025-third-200000069</guid>
<pubDate>Tue, 28 Oct 2025 20:00:00 GMT</pubDate>
<description>DALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2025 on Tuesday, November 11, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day t</description>
</item>
<item>
<title>Spectral AI raises $7.6 Million of Additional Growth Capital</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-raises-7-6-123000750</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-raises-7-6-123000750</guid>
<pubDate>Thu, 23 Oct 2025 12:30:00 GMT</pubDate>
<description>DALLAS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the pricing of a $7.6 million offering. The offering will provide the Company with additional growth capital for the continued expansion and development of its DeepView® System. The transaction includes the issuance of 4,000,000 shares of i</description>
</item>
<item>
<title>Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-named-time-list-120000705</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-named-time-list-120000705</guid>
<pubDate>Fri, 19 Sep 2025 12:00:00 GMT</pubDate>
<description>DALLAS, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced it has been named to TIME’s World’s Top HealthTech Companies 2025 list. The ranking, released September 18, 2025, can be viewed on Time.com. The list, compiled by TIME and Statista Inc., recognizes leading innovators advancing healthcare g</description>
</item>
<item>
<title>DeepView® System highlighted at the European Burns Association Congress</title>
<link>https://6ix.com/company/spectral-ai-inc/news/deepview-system-highlighted-european-burns-120000410</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/deepview-system-highlighted-european-burns-120000410</guid>
<pubDate>Wed, 10 Sep 2025 12:00:00 GMT</pubDate>
<description>DALLAS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its prominent role at the European Burns Association (EBA) conference, held from September 3rd – 6th in Berlin, Germany. The Company was featured in multiple presentations, highlighting its contributions to advancing burn care across the g</description>
</item>
<item>
<title>Spectral AI Announces 2025 Second Quarter Financial Results</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-announces-2025-second-200000555</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-announces-2025-second-200000555</guid>
<pubDate>Tue, 12 Aug 2025 20:00:00 GMT</pubDate>
<description>Q2 Overview Research & Development Revenue of $5.1 Million, total revenue for the first half of 2025 of $11.8 MillionStrong Cash position of $10.5 MillionSubmission of De Novo application to FDA completed in Second Quarter of 2025 DALLAS, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial</description>
</item>
<item>
<title>Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-schedules-2025-second-120000477</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-schedules-2025-second-120000477</guid>
<pubDate>Wed, 30 Jul 2025 12:00:00 GMT</pubDate>
<description>DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System and focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2025 on Tuesday, August 12, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to di</description>
</item>
<item>
<title>MDAI: DeepView De Novo Submission</title>
<link>https://6ix.com/company/spectral-ai-inc/news/mdai-deepview-de-novo-submission</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/mdai-deepview-de-novo-submission</guid>
<pubDate>Wed, 09 Jul 2025 12:27:00 GMT</pubDate>
<description>By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Last week, Spectral AI, Inc. (NASDAQ:MDAI) announced the submission of its De Novo 510(k) marketing clearance application to the FDA for the DeepView system in burn diagnosis. The submission includes data generated by the multi-center burn study that diagnosed wounds in diverse clinical settings. The achievement is a major</description>
</item>
<item>
<title>Spectral AI Announces Submission to FDA of its DeepView® System</title>
<link>https://6ix.com/company/spectral-ai-inc/news/spectral-ai-announces-submission-fda-120000694</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/spectral-ai-announces-submission-fda-120000694</guid>
<pubDate>Mon, 30 Jun 2025 12:00:00 GMT</pubDate>
<description>DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral imaging and artificial intelligence (“AI”) algorithms to predict burn healing potential, today announced the submission of its De Novo 510k marketing clearance application to the FDA for the DeepView System, intended for u</description>
</item>
<item>
<title>DeepView® System highlighted at the annual British Burn Association conference</title>
<link>https://6ix.com/company/spectral-ai-inc/news/deepview-system-highlighted-annual-british-120000905</link>
<guid isPermaLink="true">https://6ix.com/company/spectral-ai-inc/news/deepview-system-highlighted-annual-british-120000905</guid>
<pubDate>Tue, 10 Jun 2025 12:00:00 GMT</pubDate>
<description>DALLAS, June 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its prominent role at the annual British Burn Association (BBA) conference, held from June 4th – 6th in Brighton, UK. The Company was featured in multiple presentations, highlighting its contributions to advancing burn care across the globe</description>
</item>
</channel>
</rss>